The field of allogeneic hematopoietic cell transplantation (HCT) has dramatically evolved over the last decade. The successful development and application of non-myeloablative conditioning regimens has permitted a broader range of patients to undergo this form of cellular therapy. The isolation and characterization of progenitor populations and donor cells that confer beneficial anti-tumor effects without graft-versus-host disease (GVHD) promises to move the field towards the use of engineered grafts, and major inroads have been made in the use of alternative donors who are not completely matched at the MHC, expanding the possibility that haplo-identical and cord blood transplantation will become routine in the next 10 years. Along with these developments are new challenges. One major obstacle to the forward progress of HCT in all of these areas is the greater engraftment resistance encountered when the intensity of the regimen is reduced and/or the grafts are modified or transplanted between donor and recipients of increased genetic disparity. Our laboratory has studied in preclinical mouse models resistance to engraftment of purified allogeneic HSCs and ways to overcome the barriers to engraftment. Recent data show that we can now segregate the effects of immune mediated resistance from non-immune elements which prevent donor cell engraftment. The current grant aims has three Specific Aims: (1) To study the immune and non- immune barriers that resist engraftment of allogeneic HSC;(2) based upon our understanding of the mechanisms of resistance to develop novel non-myeloablative regimens;and (3) to characterize by phenotype and function the non-stem cell populations that facilitate allogeneic HSC engraftment. The overall goal is to utilize the experimental systems we have developed to further understand the biology of how hematopoietic cells are recognized and resisted. Based upon our understanding of the immune and non- immune barriers to engraftment we have a long-term goal of making allogeneic HCT safer and more effective for the treatment of malignant and non-malignant disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL087240-03
Application #
7622133
Study Section
Transplantation, Tolerance, and Tumor Immunology (TTT)
Program Officer
Di Fronzo, Nancy L
Project Start
2007-05-10
Project End
2011-04-30
Budget Start
2009-06-15
Budget End
2010-04-30
Support Year
3
Fiscal Year
2009
Total Cost
$368,267
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Müller, Antonia M S; Florek, Mareike; Kohrt, Holbrook E K et al. (2016) Blood Stem Cell Activity Is Arrested by Th1-Mediated Injury Preventing Engraftment following Nonmyeloablative Conditioning. J Immunol 197:4151-4162
Müller, Antonia M S; Poyser, Jessica; Küpper, Natascha J et al. (2014) Donor hematopoiesis in mice following total lymphoid irradiation requires host T-regulatory cells for durable engraftment. Blood 123:2882-92
Muller, Antonia M S; Shashidhar, Sumana; Kupper, Natascha J et al. (2012) Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunity. Proc Natl Acad Sci U S A 109:5820-5
Linderman, Jessica A; Shizuru, Judith A (2011) Rapid reconstitution of antibody responses following transplantation of purified allogeneic hematopoietic stem cells. J Immunol 186:4191-9
Shizuru, Judith A; Bhattacharya, Deepta; Cavazzana-Calvo, Marina (2010) The biology of allogeneic hematopoietic cell resistance. Biol Blood Marrow Transplant 16:S2-7
Muller, Antonia M S; Linderman, Jessica A; Florek, Mareike et al. (2010) Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation. Proc Natl Acad Sci U S A 107:14721-6
Cao, Thai M; Lazzeroni, Laura C; Tsai, Schickwann et al. (2009) Identification of a major susceptibility locus for lethal graft-versus-host disease in MHC-matched mice. J Immunol 183:462-9
Cao, Thai M; Thomas, Alun; Wang, Yuanyuan et al. (2009) A chromosome 16 quantitative trait locus regulates allogeneic bone marrow engraftment in nonmyeloablated mice. Blood 114:202-10
Tsao, Gabriel J; Allen, Jessica A; Logronio, Kathryn A et al. (2009) Purified hematopoietic stem cell allografts reconstitute immunity superior to bone marrow. Proc Natl Acad Sci U S A 106:3288-93
Weissman, Irving L; Shizuru, Judith A (2008) The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood 112:3543-53